Publications
221
Citations
2,878
Est. group size
~1
Recurring co-author estimate
Active years
38
Publishing since 1988
Chandrashekhar A. Kubal conducts clinical and translational research on liver transplantation, including surgical techniques, organ preservation methods, and patient outcomes. The work spans practical topics like machine perfusion (methods to keep donated organs healthy before transplant), immunosuppression drug management, and the study of disparities in who receives transplants. There is also related attention to kidney function and liver cancer in transplant patients.
Publication activity was high in the late 2010s (around 25 per year), dipped around 2021-2022, and has held steady at roughly 14-15 per year in recent years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026
Typically publishes in teams of ~9 · 19% small-team papers (≤3 authors) · across 39 venues
- Sex Disparities in Liver Transplant Vary Across Centers and Persist After MELD 3.0 Implementation
American Journal of Transplantation · 2025
- Primary Non-Function After Liver Transplant in the U.S.: Characteristics and Impact of Center Level Volume
American Journal of Transplantation · 2025
- Association of a Liver Allocation Policy Change With Domestic Travel for Liver Transplantation
Transplantation Direct · 2025
- Normothermic Machine Perfusion of Human Liver as a Platform to Study Delivery of Gene Therapy
American Journal of Transplantation · 2025
- Economic Assessment of Hypothermic Oxygenated Machine Perfusion in Liver Transplantation
American Journal of Transplantation · 2025
- Hypothermic-Oxygenated and Normothermic Machine Perfusion: A Risk-Matched Post-Hoc Comparison of the Bridge to Hope Randomized Trial with Prospectively Collected Institutional Outcomes
American Journal of Transplantation · 2025
- Decreased Rejection Severity with Hypothermic Oxygenated Perfusion: Sub Analysis from a Pivotal Multicenter Trial of HOPE for Liver Transplantation
American Journal of Transplantation · 2025
- Acute kidney injury following fatty liver ischemia-reperfusion injury: indirect protection by hepatic ferroptosis inhibition
Frontiers in Physiology · 2025
- Renal Function in Sequential Living Kidney‐Then‐Liver Donors Undergoing Right Lobe Donation: A Two‐Center Case Study
Clinical Transplantation · 2025
- Social Determinants Are Important Barriers to Completion of the Liver Transplant Pathway and Are Associated with Waitlisting and Mortality in Hepatocellular Carcinoma
Digestive Diseases and Sciences · 2025
- Exacerbated ischemia-reperfusion injury in fatty livers is mediated by lipid peroxidation stress and ferroptosis
Surgery · 2024
- Reappraisal of tacrolimus levels after liver transplant for HCC: A multicenter study toward personalized immunosuppression regimen
Liver Transplantation · 2024
- Racial Disparities in Liver Transplant for Hepatitis C-Associated Hepatocellular Carcinoma
Annals of Surgical Oncology · 2024
- ASO Visual Abstract: Racial Disparities in Liver Transplant for Hepatitis C-Associated Hepatocellular Carcinoma
Annals of Surgical Oncology · 2024
- Role of continuous renal replacement therapy in management of the preliver transplant patient
Current Opinion in Organ Transplantation · 2024
- Transplantation×19
- Liver Transplantation×12
- American Journal of Transplantation×10
- Transplantation Proceedings×9
- Clinical Transplantation×8
- Richard S. Mangus
Medicine · Indiana University
- Sylvester M. Black
Medicine · The Ohio State University
- Plamen Mihaylov
Medicine · Indiana University
- Musab Alebrahim
Medicine · The Ohio State University
- Megan A. Adams
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Sep 1, 2026.
Claim or correct this profile